Evidence map›Paper›PMID 27293148›Full record

ArticleThe Annals of thoracic surgery2016

Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection.

Erin M Schumer, Matthew C Black, Michael Bousamra, Jaimin R Trivedi, Mingxiao Li, Xiao-An Fu, Victor van Berkel

Abstract read
In one paragraph

Article in The Annals of thoracic surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erin M SchumerDepartment of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.
Matthew C BlackDepartment of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.
Michael BousamraDepartment of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.
Jaimin R TrivediDepartment of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky.
Mingxiao LiDepartment of Chemical Engineering, University of Louisville, Louisville, Kentucky.
Xiao-An FuDepartment of Chemical Engineering, University of Louisville, Louisville, Kentucky.
Victor van BerkelDepartment of Cardiovascular and Thoracic Surgery, University of Louisville, Louisville, Kentucky. Electronic address: victor.vanberkel@louisville.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundQuantitative analysis of specific exhaled carbonyl compounds (ECCs) has shown promise for the detection of lung cancer. The purpose of this study is to demonstrate the normalization of ECCs in patients after lung cancer resection.

methodsPatients from a single center gave consent and were enrolled in the study from 2011 onward. Breath analysis was performed on lung cancer patients before and after surgical resection of their tumors. One liter of breath from a single exhalation was collected and evacuated over a silicon microchip. Carbonyls were captured by oximation reaction and analyzed by mass spectrometry. Concentrations of four cancer-specific ECCs were measured and compared by using the Wilcoxon test. A given cancer marker was considered elevated at 1.5 or more standard deviations greater than the mean of the control population.

resultsThere were 34 cancer patients with paired samples and 187 control subjects. The median values after resection were significantly lower for all four ECCs and were equivalent to the control patient values for three of the four ECCs.

conclusionsThe analysis of ECCs demonstrates reduction to the level of control patients after surgical resection for lung cancer. This technology has the potential to be a useful tool to detect disease after lung cancer resection. Continued follow-up will determine whether subsequent elevation of ECCs is indicative of recurrent disease.

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorBreath TestsButanonesCohort StudiesExhalationFemaleHumansLung NeoplasmsMaleMiddle AgedPneumonectomyPostoperative CarePrognosisBiomarkers, TumorButanonesVolatile Organic Compounds

Identifiers

PMID27293148
PMCPMC5042568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.